Search results
PROMOTED
Author(s):
Brad Wilson
,
Devi Nair
Added:
1 month ago
Brad Wilson (Radcliffe Cardiology) is joined by Dr Devi Nair, Course Director of Rhythm Interventions Online (RIO), for a conversation charting the evolution of one of the arrhythmia community's most distinctive global education platforms.Since its launch as a virtual meeting, RIO has grown into a major international forum for electrophysiology — bringing together thousands of physicians, diverse…
View more
Medical Therapy of Heart Failure and AF
Author(s):
Gregory Burkman
,
Gerald V Naccarelli
Added:
1 week ago
Review Article
AV Junction Ablation and Device Therapy in AF
Author(s):
Arnaud Bisson
,
Thibaut Lenormand
,
Mathieu Jacobs
,
et al
Added:
4 months ago
Review Article
Author(s):
Blandine Mondésert, Ulrika Birgersdotter-Green, Pier D Lambiase ,et al
Start date:
Oct 23, 2024
This session covers the latest data on transvenous and subcutaneous ICD devices, focusing on shared decision-making and their practical applications in preventing sudden cardiac death. Moderated by Dr Blandine Mondésert (Montreal Heart Institute and University of Montreal, CA) and Dr Ulrika Birgersdotter-Green (University of California San Diego, US), this webinar delves into the long-term…
View more
Real-world Outcomes of AVNA: 10-year Results
Author(s):
Anette Caroline Kõre
,
Martin Serg
,
Tuljo Ööbik
,
et al
Added:
3 months ago
Original Research
Author(s):
Léa Benabou
,
Marmar Vaseghi
Added:
4 months ago
Shaun R Opie
Job title: Medical Scientist, Department of Gene and Cell Research
Author
Author(s):
Christophe Leclercq
Added:
1 year ago
EHRA 2025 - Outcomes from cardiac resynchronization therapy (CRT) with MultiPoint pacing (MPP) to treat patients who are not responding to standard CRT show that MPP does not improve the conversion rate of non-responders to responders compared to standard CRT; however, a reduction in HF hospitalisation was seen in the group receiving MPP.Prof Christophe Leclercq (Centre Hospitalier Universitaire…
View more
Roger J Hajjar
Job title: MD Icahn School of Medicine at Mount Sinai, New York, NY, USA
Author
Author(s):
Gi-Byoung Nam
,
Min Soo Cho
Added:
1 year ago
ESC Congress 2024 — Edoxaban monotherapy significantly improves outcomes in high-risk patients with CAD and atrial fibrillation.Investigators, Dr Gi-Byoung Nam (Ulsan University Hospital, Ulsan, SK) and Dr Min Soo Cho (Asan Medical Center, Seoul, SK) join us to discuss the key findings from the EPIC-CAD trial (NCT03718559).This Korean multi-centre, open-labelled, randomised controlled study…
View more